Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis.

Karin, Monika; Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Roengvoraphoj, Olarn; Tufman, Amanda; Belka, Claus; Manapov, Farkhad

Karin, Monika; Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Roengvoraphoj, Olarn; Tufman, Amanda; Belka, Claus; Manapov, Farkhad.

Afiliación

Karin M; Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, 81377 Munich, Germany.
Taugner J; Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, 81377 Munich, Germany.
Käsmann L; Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, 81377 Munich, Germany.
Eze C; Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Center for Lung Research (DZL), 81377 Munich, Germany.
Roengvoraphoj O; German Cancer Consortium (DKTK), Partner Site Munich, 80336 Munich, Germany.
Tufman A; Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, 81377 Munich, Germany.
Belka C; Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, 81377 Munich, Germany.
Manapov F; Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Center for Lung Research (DZL), 81377 Munich, Germany.

Cancers (Basel) ; 12(10)2020 Oct 19.

Article en En | MEDLINE | ID: mdl-33086481

Palabras clave

NSCLC; multimodal treatment; prognostic factor; stage III; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google